# Lonza Guangzhou Pharmaceutical Ltd. – FDA Inspection, Aug 23, 2013

Source: https://www.keypedia.com/records/fda_inspections/lonza-guangzhou-pharmaceutical-ltd/6173e794-a20c-4232-b5fe-2d603c6d7df3
Source feed: FDA_Inspections

> FDA inspection 846043 of Lonza Guangzhou Pharmaceutical Ltd., August 23, 2013. Classification: Voluntary Action Indicated (VAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 846043
- Company Name: Lonza Guangzhou Pharmaceutical Ltd.
- Inspection Date: 2013-08-23
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1292806 - 2025-10-31](https://www.keypedia.com/records/fda_inspections/lonza-guangzhou-pharmaceutical-ltd/6df8e4c7-99a4-4669-85d6-191812ef13ce)
- FDA Inspection 1077023 - 2018-12-14
- FDA Inspection 981011 - 2016-08-19
- FDA Inspection 709669 - 2010-12-04

Company: https://www.keypedia.com/companies/lonza-guangzhou-pharmaceutical-ltd/eeb8d307-3663-4559-88cd-4e0696c0b556

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c